HomeRSLS • NASDAQ
Follow
ReShape Lifesciences Inc
Previous close
$0.18
Day range
$0.19 - $0.20
Year range
$0.14 - $4.10
Market cap
4.39M USD
Avg Volume
622.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 2.16M | -22.98% |
Operating expense | 4.39M | -37.02% |
Net income | -3.53M | 71.00% |
Net profit margin | -163.99 | 62.35% |
Earnings per share | -0.92 | 91.49% |
EBITDA | -3.05M | 29.46% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.45M | -76.42% |
Total assets | 7.83M | -72.49% |
Total liabilities | 4.74M | -36.86% |
Total equity | 3.08M | — |
Shares outstanding | 13.14M | — |
Price to book | 0.20 | — |
Return on assets | -78.84% | — |
Return on capital | -149.00% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -3.53M | 71.00% |
Cash from operations | -2.78M | 47.28% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -338.00K | -11,366.67% |
Net change in cash | -3.12M | 41.16% |
Free cash flow | -1.58M | 50.60% |
About
Founded
2002
Headquarters
Website
Employees
40